Direct interaction between selenoprotein R and Aβ42.

Area of Science:

• Neuroscience
• Biochemistry
• Molecular Biology

Background:

• Amyloid-beta (Aβ) peptide aggregation is central to Alzheimer's disease (AD) progression.
• The redox state of methionine at position 35 (Met35) in Aβ influences its biological activity and aggregation pathway.
• Selenoprotein R (SelR), an antioxidative selenoenzyme, reduces oxidized methionine (MetO) to methionine (Met), maintaining cellular redox balance.

Purpose of the Study:

• To investigate the relationship between Selenoprotein R (SelR) and amyloid-beta (Aβ) in the context of Alzheimer's disease.
• To determine if SelR directly interacts with Aβ42 and modulates its aggregation.

Main Methods:

• Fluorescence resonance energy transfer (FRET) assays to detect direct interaction.
• Co-immunoprecipitation (co-IP) to confirm binding.
• Pull-down assays to further validate the interaction between SelR and Aβ42.

Main Results:

• Direct interaction between SelR and Aβ42 was confirmed using FRET, co-IP, and pull-down assays.
• SelR's ability to modulate Aβ42 aggregation was demonstrated.
• The findings highlight SelR's potential role in the biological functions within the human brain relevant to AD.

Conclusions:

• Selenoprotein R directly interacts with Aβ42.
• SelR has the capacity to modulate Aβ42 aggregation, suggesting a potential role in Alzheimer's disease pathogenesis.
• This study opens a novel research avenue for exploring SelR's mechanism in AD prevention.